Letters to HCPs

Important information for Healthcare Professionals

Tecentriq (atezolizumab): Risk of Severe Cutaneous Adverse Reactions (SCARs)

Direct Healthcare Professional Communication for the risk of severe cutaneous adverse reactions

For Healthcare Professionals